Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06594952
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-02
Brief Title:
Evaluation of Maternal Mental Health Following Ultrasonography Detection of Fetal Congenital Anomalies
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Maternal Mental Health Following Ultrasonography Detection of Fetal Congenital Anomalies
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate maternal mental health during antenatal and postnatal periods after Ultrasonography diagnosis of fetal anomalies
Detailed Description:
Fetal congenital anomalies are responsible for a great deal of abortions in desired pregnancies In clinical practice prenatal screening programs in 1st and 2nd trimester target both chromosomal and structural abnormalities These congenital anomalies are classified as minor and major anomalies than may lead to death or stillbirth Half of all anomalies are detectable during weeks 18-22 of pregnancy Due to the advances occurring in Ultrasonography and screening paradigms the rate of diagnosed anomalies is increasing dramatically which in turn leading to psychological distress in the pregnant mother Receiving a diagnosis of fetal anomaly is a highly stressful and potentially traumatic event that can elicit immediate feelings of grief loss anger depression and anxiety However the foreknowledge of a fetal anomaly during pregnancy may enable the mother to prepare mentally resulting in reduced maternal stress after delivery The American College of Medical Genetics recommends underscoring the importance of psychological assessment and substantive communication with parents facing a prenatal diagnosis of fetal anomaly Despite the accessibility of establishing the significant symptoms of maternal psychological distress the evidence on the definite nature of this distress in consideration to other life stressors and an accurate the prediction of women vulnerability in the critical period have not been clear yet due to many methodological issues Identification of women at highest risk for poor adaptation to the diagnosis may allow for targeted psychological support services for those most vulnerable
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None